BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 24550101)

  • 21. Extracellular stability of nanoparticulate drug carriers.
    Liu KC; Yeo Y
    Arch Pharm Res; 2014 Jan; 37(1):16-23. PubMed ID: 24214175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanoparticle-assisted combination therapies for effective cancer treatment.
    Hu CM; Aryal S; Zhang L
    Ther Deliv; 2010 Aug; 1(2):323-34. PubMed ID: 22816135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimuli-responsive polymeric nanoparticles for nanomedicine.
    Crucho CI
    ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telodendrimer-based nanocarriers for the treatment of ovarian cancer.
    Xiao K; Suby N; Li Y; Lam KS
    Ther Deliv; 2013 Oct; 4(10):1279-92. PubMed ID: 24116912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.
    Kibria G; Hatakeyama H; Harashima H
    Arch Pharm Res; 2014 Jan; 37(1):4-15. PubMed ID: 24272889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiological barrier nanovector technology for cancer applications.
    Sakamoto J; Annapragada A; Decuzzi P; Ferrari M
    Expert Opin Drug Deliv; 2007 Jul; 4(4):359-69. PubMed ID: 17683250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic therapeutic delivery using navigable agents.
    Martel S
    Ther Deliv; 2014 Feb; 5(2):189-204. PubMed ID: 24483196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nano drug-delivery systems in cancer therapy: gains, pitfalls and considerations in DMPK and PD.
    Elbayoumi TA
    Ther Deliv; 2010 Aug; 1(2):215-9. PubMed ID: 22816128
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect.
    Sajja HK; East MP; Mao H; Wang YA; Nie S; Yang L
    Curr Drug Discov Technol; 2009 Mar; 6(1):43-51. PubMed ID: 19275541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New views and insights into intracellular trafficking of drug-delivery systems by fluorescence fluctuation spectroscopy.
    Coppola S; Caracciolo G
    Ther Deliv; 2014 Feb; 5(2):173-88. PubMed ID: 24483195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of Targeted Nanostructured Coordination Polymers (NCPs) for Cancer Therapy.
    Novio F
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32751178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biophotonic techniques for manipulation and characterization of drug delivery nanosystems in cancer therapy.
    Spyratou E; Makropoulou M; Mourelatou EA; Demetzos C
    Cancer Lett; 2012 Dec; 327(1-2):111-22. PubMed ID: 22265863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.
    Anchordoquy TJ; Barenholz Y; Boraschi D; Chorny M; Decuzzi P; Dobrovolskaia MA; Farhangrazi ZS; Farrell D; Gabizon A; Ghandehari H; Godin B; La-Beck NM; Ljubimova J; Moghimi SM; Pagliaro L; Park JH; Peer D; Ruoslahti E; Serkova NJ; Simberg D
    ACS Nano; 2017 Jan; 11(1):12-18. PubMed ID: 28068099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
    Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
    Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendronized Systems for the Delivery of Chemotherapeutics.
    Dockery L; Daniel MC
    Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.
    Shi J; Xiao Z; Kamaly N; Farokhzad OC
    Acc Chem Res; 2011 Oct; 44(10):1123-34. PubMed ID: 21692448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gold nanoparticle (AuNP)-based drug delivery and molecular imaging for biomedical applications.
    Jeong EH; Jung G; Hong CA; Lee H
    Arch Pharm Res; 2014 Jan; 37(1):53-9. PubMed ID: 24214174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.